Hainan Haiyao announced that its wholly-owned subsidiary Haikou Pharmaceutical Factory Co., Ltd. recently obtained the approval and issuance of the “Drug Supplement Application Approval Notice” for the chemical “cefazoxime sodium for injection” from the State Drug Administration. Through consistent evaluation of the quality and efficacy of generic drugs, the drug is conducive to improving market competitiveness and has a positive impact on the company's performance. Cefazoxime sodium is a third-generation broad-spectrum semi-synthetic cephalosporin antibiotic. It is suitable for lower respiratory infections, urinary tract infections, abdominal infections, pelvic infections, sepsis, skin and soft tissue infections, bone and joint infections, meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, and simple gonorrhea.

Hainan Haiyao announced that its wholly-owned subsidiary Haikou Pharmaceutical Factory Co., Ltd. recently obtained the approval and issuance of the “Drug Supplement Application Approval Notice” for the chemical “cefazoxime sodium for injection” from the State Drug Administration. Through consistent evaluation of the quality and efficacy of generic drugs, the drug is conducive to improving market competitiveness and has a positive impact on the company's performance. Cefazoxime sodium is a third-generation broad-spectrum semi-synthetic cephalosporin antibiotic. It is suitable for lower respiratory infections, urinary tract infections, abdominal infections, pelvic infections, sepsis, skin and soft tissue infections, bone and joint infections, meningitis caused by Streptococcus pneumoniae or Haemophilus influenzae, and simple gonorrhea.